Based on results of a feasibility study, researchers in the United Kingdom have decided to move forward with a full randomized controlled trial comparing partial prostate ablation (PA) with radical prostatectomy (RP) in patients with intermediate-risk prostate cancer, according to a presentation at the 2017 American Urological Association Annual Meeting.
In terms of QoL data, initial responses suggested that there are some potential health gains for patients who received PA compared with RP. However, in terms of essential function and QoL as time went on, there was no significant difference in patient perception.
Leslie T, Davies L, Elliott D, et al. The PART trial—a phase III study comparing Partial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk prostate cancer—early data from the feasibility study. Presented at: 2017 American Urological Association Annual Meeting; May 12-16, 2017; Boston, MA. Abstract PD56-08. https://www.eventscribe.com/2017/AUA2017/.
... to read the full story